{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:48:04Z","timestamp":1791582484330,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630044"],"award-info":[{"award-number":["81630044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771763"],"award-info":[{"award-number":["81771763"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81788101"],"award-info":[{"award-number":["81788101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071840"],"award-info":[{"award-number":["82071840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-016"],"award-info":[{"award-number":["2021-I2M-1-016"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-017"],"award-info":[{"award-number":["2021-I2M-1-017"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-040"],"award-info":[{"award-number":["2021-I2M-1-040"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-047"],"award-info":[{"award-number":["2021-I2M-1-047"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.clim.2021.108909","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T11:56:29Z","timestamp":1639396589000},"page":"108909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Monoclonal gammopathy in autoimmune diseases: Analysis and follow-up of 160 cases in a tertiary center in China"],"prefix":"10.1016","volume":"234","author":[{"given":"Huazhen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clim.2021.108909_bb0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol. Today"},{"issue":"1","key":"10.1016\/j.clim.2021.108909_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12660","article-title":"Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: a B-cell immunomics approach","volume":"284","author":"Tipton","year":"2018","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.clim.2021.108909_bb0015","first-page":"12","article-title":"Monoclonal gammopathy and rheumatic diseases","volume":"39","author":"Raposo","year":"2014","journal-title":"Acta Reumatol. Port."},{"issue":"1\u20132","key":"10.1016\/j.clim.2021.108909_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2012.01.010","article-title":"Monoclonal gammopathy related to Sj\u00f6gren syndrome: a key marker of disease prognosis and outcomes","volume":"39","author":"Brito-Zer\u00f3n","year":"2012","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.clim.2021.108909_bb0025","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s10067-018-4064-8","article-title":"Monoclonal gammopathy in rheumatic diseases","volume":"37","author":"Yang","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.clim.2021.108909_bb0030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.autrev.2014.08.016","article-title":"Systemic sclerosis and prevalence of monoclonal immunoglobulin","volume":"13","author":"Trad","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.clim.2021.108909_bb0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3899\/jrheum.111054","article-title":"Prevalence of monoclonal gammopathy among patients with psoriatic arthritis","volume":"39","author":"Eder","year":"2012","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2021.108909_bb0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working G","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.clim.2021.108909_bb0045","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.clim.2021.108909_bb0050","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9727","key":"10.1016\/j.clim.2021.108909_bb0055","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clim.2021.108909_bb0060","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S2352-3026(14)70001-8","article-title":"Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study","volume":"1","author":"Kyle","year":"2014","journal-title":"Lancet Haematol."},{"issue":"2","key":"10.1016\/j.clim.2021.108909_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/sonc.2003.50062","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance","volume":"30","author":"Kyle","year":"2003","journal-title":"Semin. Oncol."},{"issue":"6","key":"10.1016\/j.clim.2021.108909_bb0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0961203307079045","article-title":"Monoclonal gammopathy in systemic lupus erythematosus","volume":"16","author":"Ali","year":"2007","journal-title":"Lupus"},{"issue":"24","key":"10.1016\/j.clim.2021.108909_bb0075","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","article-title":"Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study","volume":"118","author":"Lindqvist","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clim.2021.108909_bb0080","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2021.108909_bb0085","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.clim.2021.108909_bb0090","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.clim.2021.108909_bb0095","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2021.108909_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clim.2021.108909_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clim.2021.108909_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.clim.2021.108909_bb0115","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clim.2021.108909_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2021.108909_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Ohara H (2012) comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)","volume":"22","author":"Umehara","year":"2011","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2021.108909_bb0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2021.108909_bb0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","article-title":"The diagnosis and classification of undifferentiated connective tissue diseases","volume":"48-49","author":"Mosca","year":"2014","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.clim.2021.108909_bb0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.clim.2021.108909_bb0145","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clim.2021.108909_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.clim.2021.108909_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ard.44.2.109","article-title":"Demonstration and identification of monoclonal proteins in the urine of patients with Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Moutsopoulos","year":"1985","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clim.2021.108909_bb0160","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/ard.50.5.290","article-title":"Prognostic significance of paraproteinaemia in rheumatoid arthritis","volume":"50","author":"Kelly","year":"1991","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2021.108909_bb0165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1756-185X.12267","article-title":"A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: is there a link between the two diseases?","volume":"17","author":"Cho","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2021.108909_bb0170","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.clim.2021.108909_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2021.108909_bb0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-Centre cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.clim.2021.108909_bb0185","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/art.1780390625","article-title":"Malignancy in systemic lupus erythematosus","volume":"39","author":"Abu-Shakra","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.clim.2021.108909_bb0190","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/bloodadvances.2020003193","article-title":"Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma","volume":"5","author":"Steiner","year":"2021","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.clim.2021.108909_bb0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2021.108909_bb0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.2006.069039","article-title":"The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study","volume":"67","author":"Bernatsky","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.clim.2021.108909_bb0205","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/ard.2006.067108","article-title":"A closer look at non-Hodgkin\u2019s lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study","volume":"66","author":"L\u00f6fstr\u00f6m","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2021.108909_bb0210","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.2006.067777","article-title":"Antimalarials may influence the risk of malignancy in systemic lupus erythematosus","volume":"66","author":"Ruiz-Irastorza","year":"2007","journal-title":"Ann. Rheum. Dis."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621002461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621002461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:07:02Z","timestamp":1761494822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621002461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":42,"alternative-id":["S1521661621002461"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108909","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal gammopathy in autoimmune diseases: Analysis and follow-up of 160 cases in a tertiary center in China","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108909"}}